ARCHIVES

In a letter, ASCO reaffirms its views on oncology consolidation at FDA.

This article is from The Cancer Letter archive.

Vol. 30 No. 28 | July 9, 2004

Download PDF Visit The Full Archive

Related Articles

FDA Breakthrough Designation Granted to Pfizer’s Palbociclib

April 26, 2013

Compendium Drops Listing of Aranesp for Anemia of Cancer.

February 23, 2007

Francis Collins Nominated For NIH Director Two Days After Final Stem Cell Guidelines Released.

July 10, 2009

Funding Opportunities: NCI Offers Funds To Develop, Validate Mouse Models

November 20, 1998

SEER Expects To Lower Cancer Incidence Rates for Blacks by 3%

September 27, 2002

Funding opportunities listed.

January 16, 2004